25 fewer sets in 4DN-only Data.
Included Properties
Data Type
Project
Lab
Dataset
Organism
Sample Type
Sample Tier
Sample Category
Sample
Organ/System
Tissue Source
Publication
Modifications
Treatments
Assay Details
Center
Set Type
assay_subclass_short
Total Reads
Status
Commendations
Warnings
2 Common Properties
Experiment Category
Sequencing
Experiment Type
Hi-C
Title
Experiment Type
Biosample
Dataset
Condition
Assay Details
Lab
in situ Hi-C
WTC-11 differentiated to cardiac muscle cell
Hi-C on WTC-11 cardiac differention timecourse
ventricular - 23 days
Enzyme
DdeI and DpnII
in situ Hi-C
WTC-11 differentiated to cardiac muscle cell
Hi-C on WTC-11 cardiac differention timecourse
ventricular - 11 days
Enzyme
DdeI and DpnII
in situ Hi-C
WTC-11 differentiated to primitive cardiac myocyte
Hi-C on WTC-11 cardiac differention timecourse
ventricular - 6 days
Enzyme
DdeI and DpnII
in situ Hi-C
WTC-11
Hi-C on WTC-11 cardiac differention timecourse
undifferentiated
Enzyme
DdeI and DpnII
in situ Hi-C
dTAG-NIPBL hTERT-RPE-1 - clone D7
Hi-C on hTert-RPE1 with degron tagged NIBPL
clone D7 mitotic 8 hr post release DMSO control
Enzyme
Arima - A1, A2
in situ Hi-C
heart left ventricle
in situ Hi-C on primary human cardiomyocytes
left ventricle - donor 01199
Enzyme
DpnII
in situ Hi-C
heart left atrium
in situ Hi-C on primary human cardiomyocytes
left atrium - donor 01199
Enzyme
DpnII
in situ Hi-C
scid.adh
Hi-C on Scid.adh cells
CRISPR modified- Knockout tcf7
Enzyme
Arima - A1, A2
in situ Hi-C
WTC-11 differentiated to cardiac muscle cell
in situ Hi-C on an allelic series of iPSCs differentiated to cardiac cells
TBX5 homozygous (compound heterozygous) WTC-11-derived cardiac myocytes - differentiation day 23
Enzyme
Arima - A1, A2
in situ Hi-C
WTC-11 differentiated to cardiac muscle cell
in situ Hi-C on an allelic series of iPSCs differentiated to cardiac cells
TBX5 heterozygous WTC-11-derived cardiac myocytes - differentiation day 23
Enzyme
Arima - A1, A2
in situ Hi-C
WTC-11 differentiated to cardiac muscle cell
in situ Hi-C on an allelic series of iPSCs differentiated to cardiac cells
Crispr treated, unmodified control WTC-11-derived cardiac myocytes - differentiation day 23
Enzyme
Arima - A1, A2
in situ Hi-C
WTC-11 differentiated to cardiac muscle cell
in situ Hi-C on an allelic series of iPSCs differentiated to cardiac cells
Untreated, unmodified WTC-11-derived cardiac myocytes - differentiation day 23
Enzyme
Arima - A1, A2
in situ Hi-C
cerebellum - PND 22
Hi-C on mouse cerebellar tissue
PND 22
Enzyme
MboI
in situ Hi-C
cerebellum - PND 6
Hi-C on mouse cerebellar tissue
PND 6
Enzyme
MboI
Micro-C
H1-hESC (Tier 1) differentiated to definitive endoderm
Micro-C on H1-DE cells - protocol variations
Formaldehyde+DSG, H1-DE (Tier 1)
Enzyme
MNase
in situ Hi-C
HFFc6 (Tier 1)
Hi-C on HFF cells - protocol variations
Formaldehyde+DSG, DpnII, HFFc6 (Tier 1)
Enzyme
DpnII
in situ Hi-C
HFFc6 (Tier 1)
Hi-C on HFF cells - protocol variations
Formaldehyde+DSG, DdeI and DpnII, HFFc6 (Tier 1)
Enzyme
DdeI and DpnII
in situ Hi-C
HFFc6 (Tier 1)
Hi-C on HFF cells - protocol variations
Formaldehyde+DSG, DdeI, HFFc6, (Tier 1)
Enzyme
DdeI
in situ Hi-C
H1-hESC (Tier 1) differentiated to definitive endoderm
Hi-C on H1-DE cells - protocol variations
Formaldehyde, DpnII, H1-DE (Tier 1)
Enzyme
DpnII
in situ Hi-C
H1-hESC differentiated to definitive endoderm
Hi-C on H1-DE cells - protocol variations
Formaldehyde, DpnII
Enzyme
DpnII
in situ Hi-C
H1-hESC (Tier 1)
Hi-C on H1 cells - protocol variations
Formaldehyde+DSG, DpnII, H1-hESC (Tier 1)
Enzyme
DpnII
in situ Hi-C
CyT49
Hi-C on hESC differentiated to pancreatic endoderm
undifferentiated
Enzyme
MboI
in situ Hi-C
CyT49 differentiated to pancreatic endoderm
Hi-C on hESC differentiated to pancreatic endoderm
pancreatic endoderm
Enzyme
MboI
in situ Hi-C
CyT49 differentiated to endoderm of foregut
Hi-C on hESC differentiated to pancreatic endoderm
gut endoderm
Enzyme
MboI
in situ Hi-C
CyT49 differentiated to definitive endoderm
Hi-C on hESC differentiated to pancreatic endoderm
definitive endoderm
Enzyme
MboI